0
0

Prescription Drug Affordability and Access Act

2/9/2022, 3:26 AM

Congressional Summary of S 3166

Prescription Drug Affordability and Access Act

This bill addresses prescription drug costs and access. For example, the bill (1) establishes within the Department of Health and Human Services the Bureau of Prescription Drug Affordability and Access to review the wholesale acquisition costs of prescription drugs, and (2) authorizes the Centers for Medicare & Medicaid Services to negotiate Medicare drug prices.

Current Status of Bill S 3166

Bill S 3166 is currently in the status of Bill Introduced since January 8, 2020. Bill S 3166 was introduced during Congress 116 and was introduced to the Senate on January 8, 2020.  Bill S 3166's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 8, 2020

Bipartisan Support of Bill S 3166

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill S 3166

Primary Policy Focus

Health

Potential Impact Areas

- Advisory bodies
- Business records
- Congressional oversight
- Corporate finance and management
- Department of Health and Human Services
- Executive agency funding and structure
- Government information and archives
- Government studies and investigations
- Health care costs and insurance
- Health care coverage and access
- Health programs administration and funding
- Inflation and prices
- Intellectual property
- Manufacturing
- Prescription drugs
- Retail and wholesale trades

Alternate Title(s) of Bill S 3166

Prescription Drug Affordability and Access Act
Prescription Drug Affordability and Access Act
A bill to lower the cost of drugs for all Americans.

Comments